Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus granulosus | enteropeptidase | 0.0217618 | 0.110084 | 1 |
Echinococcus multilocularis | enteropeptidase | 0.0217618 | 0.110084 | 1 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0217618 | 0.110084 | 0.214927 |
Echinococcus multilocularis | glycoprotein Antigen 5 | 0.0217618 | 0.110084 | 1 |
Echinococcus granulosus | glycoprotein Antigen 5 | 0.0217618 | 0.110084 | 1 |
Toxoplasma gondii | PAN domain-containing protein | 0.0672938 | 1 | 0.5 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0418921 | 0.503527 | 0.983079 |
Onchocerca volvulus | 0.0257626 | 0.18828 | 0.373922 | |
Toxoplasma gondii | PAN domain-containing protein | 0.0672938 | 1 | 0.5 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0165729 | 0.0086669 | 0.0169211 |
Schistosoma mansoni | subfamily S1A unassigned peptidase (S01 family) | 0.0423355 | 0.512194 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0418921 | 0.503527 | 1 |
Mycobacterium ulcerans | hypothetical protein | 0.0161294 | 0 | 0.5 |
Echinococcus granulosus | Mastin | 0.0217618 | 0.110084 | 1 |
Brugia malayi | Trypsin family protein | 0.0418921 | 0.503527 | 1 |
Onchocerca volvulus | 0.0418921 | 0.503527 | 1 | |
Loa Loa (eye worm) | hypothetical protein | 0.0418921 | 0.503527 | 1 |
Echinococcus multilocularis | Mastin | 0.0217618 | 0.110084 | 1 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Cytotoxicity (functional) | = 0 % | Cytotoxicity against MRC-5 cells at concentration 32 microM | ChEMBL. | 11356101 |
Cytotoxicity (functional) | = 0 % | Cytotoxicity against MRC-5 cells at concentration 8 microM | ChEMBL. | 11356101 |
Cytotoxicity (functional) | = 0 % | Cytotoxicity against MRC-5 cells at concentration 1 microM | ChEMBL. | 11356101 |
Cytotoxicity (functional) | = 0 % | Cytotoxicity against MRC-5 cells at concentration 0.5 microM | ChEMBL. | 11356101 |
Cytotoxicity (functional) | 0 % | In vitro cytotoxic activity against mouse peritonealmacrophages at a concentration 32 microM. | ChEMBL. | 11356101 |
Cytotoxicity (functional) | 0 % | In vitro cytotoxic activity against mouse peritoneal macrophages at a concentration 8 microM; Non-toxic | ChEMBL. | 11356101 |
Cytotoxicity (functional) | 0 % | In vitro cytotoxic activity against mouse peritoneal macrophages at a concentration 2 microM; Non-toxic | ChEMBL. | 11356101 |
Cytotoxicity (functional) | = 0 % | Cytotoxicity against MRC-5 cells at concentration 32 microM | ChEMBL. | 11356101 |
Cytotoxicity (functional) | = 0 % | Cytotoxicity against MRC-5 cells at concentration 8 microM | ChEMBL. | 11356101 |
Cytotoxicity (functional) | = 0 % | Cytotoxicity against MRC-5 cells at concentration 1 microM | ChEMBL. | 11356101 |
Cytotoxicity (functional) | = 0 % | Cytotoxicity against MRC-5 cells at concentration 0.5 microM | ChEMBL. | 11356101 |
IC50 (functional) | = 21.9 nM | In vitro growth inhibition of P. falciparum D6 strain | ChEMBL. | 11356101 |
IC50 (functional) | = 21.9 nM | In vitro growth inhibition of P. falciparum D6 strain | ChEMBL. | 11356101 |
IC50 (functional) | = 23.7 nM | In vitro growth inhibition of P. falciparum F32 strain | ChEMBL. | 11356101 |
IC50 (functional) | = 23.7 nM | In vitro growth inhibition of P. falciparum F32 strain | ChEMBL. | 11356101 |
IC50 (functional) | = 29.5 nM | In vitro growth inhibition of P. falciparum W2 strain | ChEMBL. | 11356101 |
IC50 (functional) | = 29.5 nM | In vitro growth inhibition of P. falciparum W2 strain | ChEMBL. | 11356101 |
IC50 (functional) | = 38.1 nM | In vitro growth inhibition of P. falciparum FcB1R strain | ChEMBL. | 11356101 |
IC50 (functional) | = 38.1 nM | In vitro growth inhibition of P. falciparum FcB1R strain | ChEMBL. | 11356101 |
Species name | Source | Reference | Is orphan |
---|---|---|---|
Plasmodium falciparum | ChEMBL23 | 11356101 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.
1 literature reference was collected for this gene.